MW
Dr. Marianne Whitcombe
Chief Executive Officer
Two decades in specialty devices, focused on bringing combination products from bench through regulatory review.
Leadership
The people accountable for what we put inside the body.
AF
Dr. Aaron Feld
Chief Scientific Officer
Polymer and coating scientist; leads the biomaterials and elution programmes that underpin every platform.
PR
Priya Raman
Chief Medical Officer
Interventional background, responsible for clinical strategy across cardiovascular and oncology programmes.
DO
Daniel Okonkwo
Chief Financial Officer
Oversees capital strategy, partnership economics and reporting for the company's licensed platforms.
HM
Hélène Marchand
VP, Regulatory & Quality
Guides combination-product submissions across Canadian, US and EU pathways.
TL
Tomas Lindqvist
VP, Device Engineering
Leads implantable device design, from scaffold mechanics to coating process transfer.
Board of directors
Dr. Susan Ojo
Chair
Robert Mercier
Audit Committee Chair
Dr. Ines Haddad
Science & Technology Committee
Grace Lindberg
Compensation Committee